PetMed Express delays FY2025 10-K; Audit Committee probes whistleblower reports on revenue recognition

PETMED EXPRESS INC

10-K filing delayed beyond July 1 extension; Audit Committee investigating anonymous whistleblower reports.
Reports focus on timing of revenue recognition for Q4 autoship orders and a $50 coupon promotion's effect on new customer KPIs.
Investigation ongoing with external legal counsel; no conclusions yet; company does not expect material impact on preliminary results.
Company working to file 10-K as soon as practicable; no definitive timeline provided.

item 7.01 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001040130-25-000036
form_type: 8-K
ticker: PETS
cik: 0001040130
company_name: PETMED EXPRESS INC
filed_at: 2025-07-01T23:59:59+00:00
discovered_at: 2026-05-14T18:02:43.175509+00:00
generated_at: 2026-05-18T09:52:08.699012+00:00
sec_items: ["7.01", "8.01", "9.01"]
event_type: regulatory
sentiment: negative
materiality_score: 0.7
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001040130-25-000036
json_url: https://secwatch.observer/filing/0001040130-25-000036.json
markdown_url: https://secwatch.observer/filing/0001040130-25-000036.md
text_url: https://secwatch.observer/filing/0001040130-25-000036.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1040130/000104013025000036/0001040130-25-000036-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1040130/000104013025000036/pets-20250701.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001040130-25-000036

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.